Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 8:59 PM ET

Healthcare Equipment and Supplies

Company Overview of Nobel Biocare Holding AG

Company Overview

Nobel Biocare Holding AG operates in the field of implant-based dental restorations worldwide. It offers dental implants for various indications, bone types, and surgical protocols under the NobelActive, Brånemark System, and NobelReplace brands; high-precision individualized prosthetics and CAD/CAM systems for every indication, from a single tooth to edentulous jaws, on natural teeth and implants under the NobelProcera brand; and machined and TiUnite implants. The company also provides a range of individualized CAD/CAM abutments and a portfolio of prefabricated temporary and final abutments; biomaterials for soft tissue and bone regeneration under the creos brand; and removable and fixed im...

Balz Zimmermann-Strasse 7

Balsberg

Kloten,  8302

Switzerland

Founded in 1981

2,552 Employees

Phone:

41 43 211 42 00

Fax:

41 43 211 42 42

Key Executives for Nobel Biocare Holding AG

Chief Executive Officer
Age: 58
Total Annual Compensation: $2.0M
Compensation as of Fiscal Year 2013.

Nobel Biocare Holding AG Key Developments

Nobel Biocare Unveils New Cement-Free Solution for Molar Teeth Restoration

Nobel Biocare Holding AG has unveiled a new complete, cement-free posterior treatment solution developed for restoration of molar teeth. The solution features a choice of new wide-platform implants and restorative options designed specifically for the posterior region. Also being launched at IDS is an entire new parallel-walled implant system, NobelParallel Conical Connection (CC). Nobel Biocare's new complete posterior solution incorporates new 5.5 mm wide-platform (WP) implant options. Clinicians can choose from the NobelParallel CC WP and new NobelActive WP, both designed for optimized emergence profiles for large molar crowns.

Nobel Biocare Announces Management Changes

Nobel Biocare announced that effective February 1, 2015, Mr. Tullio Di Dio will be appointed Chief Financial Officer of Nobel Biocare succeeding Mr. Oliver Walker as he has decided to leave the company to pursue his career interests outside Nobel Biocare. Mr. Di Dio joins Nobel Biocare with 23 years of finance experience including assignments at United Technologies, Roche and during the past 12 years with Danaher. Most recently, Mr. Di Dio served as Vice President, Finance for Beckman Coulter EMEA. He played an important role in integrating Beckman Coulter into Danaher.

Nobel Biocare Holding AG(SWX:NOBN) dropped from S&P EUROPE 350

Nobel Biocare Holding AG(SWX:NOBN) dropped from S&P EUROPE 350

Similar Private Companies By Industry

Company Name Region
Swisstom AG Europe
Zimmer GmbH Europe
Smith & Nephew AG Europe
Acrostak (Schweiz) AG Europe
Antares Pharma AG Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
March 9, 2015
mininavident AG
Merger/Acquisition
September 15, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Nobel Biocare Holding AG, please visit www.nobelbiocare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.